KRAS Inhibitors and Tumor Vaccines Show Promise Against Deadly Pancreatic Cancer
Pancreatic ductal adenocarcinoma stands as medicine's most stubborn adversary, with five-year survival rates below 12 percent. The disease's notorious resistan…
Found 1137 results for "cancer"
Pancreatic ductal adenocarcinoma stands as medicine's most stubborn adversary, with five-year survival rates below 12 percent. The disease's notorious resistan…
Men facing aggressive prostate cancer surgery now have compelling evidence for a treatment approach that could dramatically reduce their chances of disease rec…
Even advanced imaging technologies struggle to detect microscopic cancer spread, leaving thousands of men with incomplete pre-surgical information that could i…
The pursuit of more precise lung disease diagnosis just gained significant momentum with evidence that freezing-based biopsy tools may fundamentally improve ho…
Advanced cancer patients facing treatment failure may soon have a new therapeutic option through precision immunotherapy targeting previously untouchable tumor…
Advanced prostate cancer treatment is entering an era of precision medicine where radiation doses can be tailored to individual patients rather than using stan…
Cancer treatment stands at a pivotal juncture where single-target therapies are giving way to precision weapons capable of hitting multiple biological pathways…
Bone density screening could become far more accessible as artificial intelligence transforms routine chest CT scans into effective osteoporosis detection tool…
Advanced prostate cancer treatment is shifting toward molecularly-guided therapy combinations that could dramatically improve survival outcomes for men with ag…
A fundamental question in oncology is how cancer cells evade programmed death mechanisms that would normally eliminate malignant cells. This biochemical invest…
Researchers discovered that reduced LCP2 protein levels drive chemotherapy resistance in natural killer/T-cell lymphoma by triggering cellular senescence. When…
Blood cancer patients with autoimmune conditions face dramatically worse outcomes when receiving life-saving stem cell transplants, challenging current treatme…
The promise of bispecific antibodies in multiple myeloma faces a significant hurdle: nearly 40% of patients experience primary treatment failure. This challeng…
Young adults who survive cancer may face a cardiovascular time bomb that emerges years after their oncological victory. This reality challenges the common assu…
Medical imaging could become dramatically safer as researchers demonstrate the feasibility of reducing radiation exposure by up to 95% in whole-body PET scans…
The intersection of metabolic medicine and oncology reveals an unexpected ally in fighting one of gynecology's deadliest cancers. While ovarian cancer's late-s…
Cancer cells spreading to the liver—a deadly progression seen in uveal melanoma and colorectal cancer—may have found a molecular escape route that could become…
Multiple myeloma remains one of the most challenging blood cancers to cure, with patients typically experiencing multiple relapses despite initial treatment su…
A historically difficult-to-treat form of lung cancer may finally have an effective first-line therapy, potentially extending survival for thousands of patient…
Children carrying inherited genetic flaws face dramatically higher cancer rates throughout their lives, fundamentally changing how families should approach med…